Early palliative care improves transplant patients’ quality of life, especially for minoritized groups or those with high distress, suggesting targeted or clinician-led care.
Read More
iMMagine-1 phase 2 trial shows 97% response, 62% complete response in relapsed/refractory myeloma, with strong safety and promising 2026 launch.
Read More
Justin Balko, PharmD, PhD, recently joined Dr. Priyanka Sharma and Dr. Roberto Salgado at the 2024 San Antonio Breast Cancer Symposium to discuss immune biomarkers, including tumor-infiltrating lymphocytes, and their roles.
Read More
A quiz based on the latest COPD and asthma news from your peers.
Read More
Do you remember the COPD research presented at CHEST 2024? Test your knowledge now and see how you rank!
Read More
Do you remember the psoriasis research presented at Fall Clinical Dermatology Conference 2024? Test your knowledge now and see how you rank!
Read More
NGS aligned with FISH for detecting HER2 status in patients with breast cancer, in addition to revealing ERBB2 mutations and nuanced alterations.
Read More
Physician’s Weekly spoke with Alexey Danilov, MD, PhD, at ASH 2024 on personalized care and prognostic insights in CLL.
Read More
Recent studies, including one from the ASHP Midyear Clinical Meeting, highlight strategies for achieving equitable outcomes in patients with chronic pain.
Read More
Dr. Marla Lipsyc-Sharf reviews her recent session at the 2024 SABCS meeting, discussing biopsy approaches and treatment sequencing in metastatic breast cancer.
Read More
High tumor-infiltrating lymphocyte levels (>40%) predicted improved survival in triple-negative breast cancer, emphasizing TILs as a key prognostic biomarker.
Read More
Do you remember the recent COPD research? Test your knowledge now and see how you rank!
Read More
A quiz based on the latest news and studies on tardive dyskinesia.
Read More
Do you remember the Retinal Vascular Disease research presented at AAO 2024? Test your knowledge now and see how you rank!
Read More
Do you remember the RCC research presented at ESMO 2024? Test your knowledge now and see how you rank!
Read More
A recent study evaluated the impact of circulating plasma cells in patients with primary multiple myeloma on bortezomib-containing induction therapy.
Read More
A recent study from ASH 2024 examined the clinical features and outcomes of RT in British Columbia, comparing two eras: the chemoimmunotherapy (CIT) era (pre-2016) and the novel agents (NA) era (post-2016).
Read More
Educational programs and psychological support addressing cancer-related beliefs and promoting healthier coping strategies are crucial for improving outcomes.
Read More
A curated eBook featuring AAO 2024 retinal vascular disease-focused studies, findings, and expert opinions.
Read More
A curated eBook featuring CHEST 2024 RCC-focused studies, findings, and expert opinions.
Read More
